Depression News and Research

Latest Depression News and Research

Oligomerix to advance tau protease inhibitor program with $2M Series A financing

Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease and related neurodegenerative disorders, announced today the completion of approximately $2 million in Series A financing, which includes both issuance of new convertible preferred shares and debt conversion.

23 Apr 2012

Depression may increase risk of peripheral artery disease

Depression may be associated with an increased risk of arterial narrowing in the legs and pelvis, a condition known as peripheral artery disease (PAD), according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions in Chicago.

21 Apr 2012

Researchers revisit Charcot's vibration therapy for Parkinson's disease

In the 19th century, Jean-Martin Charcot, the celebrated neurologist, developed a "vibration chair," to relieve symptoms of Parkinson's disease. Charcot reported improvements in his patients, but he died shortly thereafter and a more complete evaluation of the therapy was never conducted.

20 Apr 2012

Mood disorders not linked to nasal obstruction

While mood disorders like depression or anxiety tend to negatively affect treatment for allergies and chronic rhinosinusitis, the same cannot be said for patients with nasal obstructions such as deviated septum, according to researchers at Henry Ford Hospital.

20 Apr 2012

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

SK Biopharmaceuticals, a South Korean pharmaceutical company, announced today that it was granted special status by the U.S. Food and Drug Administration (FDA) for carisbamate for the management of patients with infantile spasms (IS), a form of epilepsy associated with increased risk of death or mental retardation.

20 Apr 2012

Final results from MSD’s VICTRELIS plus PEGINTRON Phase III trial on HCV treatment-related anemia

MSD, known as Merck in the United States and Canada, announced final results from a Phase III, open-label study designed to compare the impact of two anaemia management strategies on sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) genotype 1 infection treated with VICTRELIS(boceprevir) in combination with PEGINTRON and ribavirin.

20 Apr 2012

Optimism could benefit the heart: A review of studies

A Harvard School of Public Health review of more than 200 studies suggests that optimism is good for the heart. The researchers looked at studies that had recorded psychological well-being and cardiovascular health. This revealed that factors such as optimism, life satisfaction, and happiness appeared to be linked associated with a reduced risk of heart and circulatory diseases, regardless of a person's age, socio-economic status, smoking status or body weight. Disease risk was 50% lower among the most optimistic individuals.

19 Apr 2012

Study demonstrates far-reaching impact of voice disorders

Patients with voice problems have nearly as many days of short-term disability claim and work productivity losses as those with chronic conditions like asthma, heart disease and depression, according to new findings from Duke University Medical Center researchers. Per claim, voice disorders account for up to 40 lost workdays and about $3,400 in short-term disability payments annually.

19 Apr 2012

Physical exercise, meditation can change brains for the better

Practices like physical exercise, certain forms of psychological counseling and meditation can all change brains for the better, and these changes can be measured with the tools of modern neuroscience, according to a review article now online at Nature Neuroscience.

19 Apr 2012

Ecstasy and speed-using grade ten students more likely to develop depression

A five year study conducted with thousands of local teenagers by University of Montreal researchers reveals that those who used speed (meth/ampthetamine) or ecstasy (MDMA) at fifteen or sixteen years of age were significantly more likely to suffer elevated depressive symptoms the following year. "Our findings are consistent with other human and animal studies that suggest long-term negative influences of synthetic drug use," said co-author Fr-d-ric N. Bri-re of the School Environment Research Group at the University of Montreal.

19 Apr 2012

Veterans with killing experience more likely to report suicidal thoughts

The experience of killing in war was strongly associated with thoughts of suicide, in a study of Vietnam-era veterans led by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.

19 Apr 2012

Link between insomnia and severity of perceived tinnitus symptoms

For the more than 36 million people plagued by tinnitus, insomnia can have a negative effect on the condition, worsening the functional and emotional toll of chronic ringing, buzzing, hissing or clicking in the head and ears, according to a new study from Henry Ford Hospital in Detroit.

19 Apr 2012

Brain size and IQ secret may lie in genes: Study

The study, conducted by a team of more than 200 scientists from 100 institutions worldwide, measured the size of the brain and its memory centers in thousands of MRI images from 21,151 healthy people while simultaneously screening their DNA. According to the researchers, a variant in a gene called HMGA2 affected the brain size, as well as a person's intelligence.

18 Apr 2012

Blood test to diagnose depression in adolescents

Researchers have developed a blood test that can diagnose depression in teens, a step they hope will lead to a better way to identify the disorder in young people. At present diagnosing depression depends entirely on a patient's willingness to report symptoms. For teens, the diagnosis is particularly challenging, given the natural emotional ups and downs of adolescence.

18 Apr 2012

EAPs fail to identify individuals who abuse their intimate partner

A new study by researchers at the Johns Hopkins Center for Injury Research and Policy and RTI International finds employee assistance programs (EAPs), a standard benefit offered to employees at most large companies, are failing to identify individuals who abuse or have the potential to abuse their intimate partner, despite well-known risk factors for intimate partner violence perpetration.

18 Apr 2012

Tai Chi designed for wheelchair users

An innovative 13-postures Tai Chi designed for wheelchair users is described in the current issue of Technology and Innovation- Proceedings of the National Academy of Inventors.

18 Apr 2012

Study supports tolerability of low-dose aripiprazole as an antidepressant therapy-augmenting agent

In the current issue of Psychotherapy and Psychosomatics there is a negative study on the use of aripiprazole in depression.

18 Apr 2012

Role of inability to express emotions in cancer

A review published in the current issue of Psychotherapy and Psychosomatics raises the issue of the role of the inability to express emotions in cancer. Several interesting hypotheses emerge such as a possible link between alexithymia and the immune system, between alexithymia and quality of life, or between alexithymia, anxiety and depression.

18 Apr 2012

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis

Idera Pharmaceuticals, Inc. today announced the treatment of the first patient in a Phase 2 clinical trial of IMO-3100, the Company's lead Toll-like receptor (TLR) inhibitor for the treatment of autoimmune diseases, in patients with moderate to severe plaque psoriasis.

18 Apr 2012

Study tests effectiveness of personally tailored exercise programmes on young people with depression

A unique study to test the effectiveness of personally tailored exercise programmes on young people with depression has been launched by researchers at The University of Nottingham.

18 Apr 2012

Depression News and Research

Latest Depression News and Research

Oligomerix to advance tau protease inhibitor program with $2M Series A financing

Depression may increase risk of peripheral artery disease

Researchers revisit Charcot's vibration therapy for Parkinson's disease

Mood disorders not linked to nasal obstruction

SK Biopharmaceuticals receives FDA Orphan Drug status for carisbamate

Final results from MSD’s VICTRELIS plus PEGINTRON Phase III trial on HCV treatment-related anemia

Optimism could benefit the heart: A review of studies

Study demonstrates far-reaching impact of voice disorders

Physical exercise, meditation can change brains for the better

Ecstasy and speed-using grade ten students more likely to develop depression

Veterans with killing experience more likely to report suicidal thoughts

Link between insomnia and severity of perceived tinnitus symptoms

Brain size and IQ secret may lie in genes: Study

Blood test to diagnose depression in adolescents

EAPs fail to identify individuals who abuse their intimate partner

Tai Chi designed for wheelchair users

Study supports tolerability of low-dose aripiprazole as an antidepressant therapy-augmenting agent

Role of inability to express emotions in cancer

Idera commences IMO-3100 Phase 2 clinical trial for psoriasis

Study tests effectiveness of personally tailored exercise programmes on young people with depression

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Depression News and Research

Latest Depression News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in